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congenital spinal muscular atrophy 
predominantly affecting the lower limbs to 
chromosome 12q23-q24
Spinal muscular atrophies are a heterogeneous group of disorders. They differ 
in time of onset, clinical presentation, progression, severity and mode of 
inheritance. In 1985 a Dutch family was described with a dominant, non­
progressive spinal muscular atrophy presenting at birth with arthrogryposis 
(MIM 600175). Linkage analysis was performed in this family. After having 
excluded the loci for Werdnig-Hoffmann’s disease and for dominant distal 
spinal muscular atrophy with upper limb predominance, we were able to 
localise the gene to a 10cM interval between the markers D12S78 and 
D12S1646 on chromosome 12q23-q24. Recently, dominant scapuloperoneal 
spinal muscular atrophy has been localised to an overlapping interval. 
However, the clinical appearances of scapuloperoneal spinal muscular 
atrophy and the present disorder make allelism unlikely. In 1994, a second 
Dutch family with a disorder similar to the present one was described. We 
excluded linkage to markers of the 12q23-q24 region in this family and thereby 
proved genetic heterogeneity of this type of dominant, congenital and 
nonprogressive spinal muscular atrophy.
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Introduction
The spinal muscular atrophies (SMAs) are a rather 
large and heterogeneous group of disorders.1'8 The 
most extensively studied condition in this group is
SMA lies in the lower motor neurons or anterior horn
Corresponding author: H. Kremer, Dept Human Genetics, 
University Hospital Nijmegen, P.O. Box 9101, 6500 HB 
Nijmegen, The Netherlands. Tel: +31.24.3615296; Fax: 
+ 31.24.3540488; Email: H.Kremer@antrg.azn.nl
fore, the most likely time of onset is during or shortly
period for differentiation of the spinal motor 
neurons.4
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A family with dominant, congenital SMA accom­
panied by contractures was described by Fleury and 
Hageman .5 The condition in this family is nonprog­
ressive and inherited in a dominant pattern. The mildly 
affected family members suffer from congenital weak­
ness of the distal parts of the lower limbs only More 
severely affected individuals show additional weakness 
of the pelvic girdle and truncal muscles, resulting in 
scoliosis. Tendon reflexes are absent or reduced and 
sensory abnormalities are not found. A similar type of 
dominant SMA has recently been described by Frijns et 
al? The condition in both families cannot be cate­
gorised in the generally accepted classification system 
of Harding10 due to its congenital nature. The disorder 
described by Fleury and Hageman can be uniformly
Typing of DNA Markers
DNA was extracted using the method described by Miller et 
t i l15 Amplification of locus-specific DNA-fragments and their 
analysis was performed according to Kremer et a l 16
Statistical Analysis of Linkage Data
rI\vo-point lod scores were calculated, using the subroutine 
Mlink of the Linkage 5.1 package.17^ 19 A gene frequency of 
0.00001 and a penetrance of 100% were assumed for the 
disorders. Calculations of maximum lod scores were per­
formed using the subroutine Iiink of the Linkage 5.1 package. 
Multipoint analysis was performed using five-point linkage 
analysis (Fastlink version 2.30)20’21 combined with the sliding 
window technique.
Results
classified as a congenital distal type. In the family Linkage to Chromosome 12q23—q24
described by Frijns et al one of the patients showed Linkage analysis was performed in the Dutch family 
involvement of the scapular muscles.
We performed linkage analysis in the family 
described by Fleury and Hageman.5 Both the loci for a 
distal form of dominant spinal muscular atrophy with
upper limb predominance on 7pn and Werdnig-Hoff- 
mann's disease on 5ql 2— were excluded. We 
localised the gene for the SMA in the present family to 
12q23-q24. The critical region overlaps with the inter­
val between the markers D12S338 and D12S366 in 
which dominant scapuloperoneal spinal muscular atro­
phy (SPSMA) is located.M The critical region for the 
present SMA in 12q23-q24 was excluded in the family 
described by Frijns et al?
Materials and Methods
Patients
For a detailed description of the patients suffering from the 
present dominant SMA we refer to the paper of Fleury and 
Hageman.s The authors discriminated four categories of 
severity. These varied from category one with slight paresis of 
foot extension and deformities of the feet to category four 
with paralysis of the distal part of the legs and serious paresis 
of the muscles of the trunk, the pelvic girdle and the proximal 
part of the legs. Additional investigations such as electro­
myography investigation of motor nerve conduction veloci­
ties and muscle and nerve biopsies, showed evidence for a 
pathology of lower motor neurons. Blood samples were 
obtained from 20 members of this family5 U) of whom were 
affected. Although individual IV-8 was marked as affected by 
Fleury and Hageman, reinvestigation did not confirm this. 
Her tendon reflexes and the strength in her feet are normal. 
Two non-affected individuals, IIM 8 and the son of 111-20, 
have been tested for markers derived from the critical region 
only. From the family described by Frijns et al7 blood samples 
were obtained from seven affected members is three genera­
tions, two non-affected members and two spouses.
described by Fleury and Hageman (family 1, Figure l) .5 
Twenty members of this family were reinvestigated and 
included in the DNA analysis. Three loci involved in 
different forms of SMA were regarded as candidates 
for the present disorder: 7pu , 5ql2~ql312,13 and 
12q24.l-q24.31.14
Chromosome 7p harbours a locus for a distal form of
SMA. The markers D7S513, D7S493, D7S516, D7S526
and GCK, derived from this locus11 made this location 
highly unlikely (Table 1). Since the proximal border of 
the critical region was not determined by Christodou- 
lou et a l"  we tested EGFR and D7S440 which 
excluded the centromeric region of chromosome 7. The 
chromosomal region involved in Werdnig-Hoffmann’s 
disease (5ql2—ql3) was excluded using the poly­
morphic markers D5S407, D5S629 and D5S118 
(Table I). Subsequently, an indication for linkage was 
obtained with the marker D12S79, derived from the 
critical region described for SPSMA. The maximum lod 
score was 1.32 at 0 = 0.08. The markers D12S366, 
D12S349 and D12S1639 located, distal to D12S79y 
showed a decrease of the lod score. Therefore, we 
started our fine mapping with polymorphisms located 
proximal to D12S79.
Fine Mapping
Nineteen polymorphic markers were tested derived 
from the region proximal to D12S79. Two-point lod 
scores between the relevant markers and the disease 
locus are given in Table 2. A maximum lod score of 5.16 
at 0 = 0.00 was obtained with the marker D12S1583. In 
order to visualise the borders of the critical region 
haplotypes were constructed (Figure 1). The proximal 
border is determined by a recombination visible in
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Figure 1 Pedigree o f family 1 and haplotypes o f individuals available for this study. Individuals are numbered according to Fleury 
and Hag email. Bars depict the chromosome carrying the mutation, The black part o f the bars represents the common disease 
haplotype and arrows indicate crossovers.
Table 1 Two-point lod scores for the candidate loci on 
chromosomes 5q and 7 in family I
family I 
Locus
0
a  oo a oi 0.05 0.10 0.20 030
D5S407 -5.35 -2.08 - 0.68 0.02 0.22
D5S629 .-■OO -"3.48 -1.58 -0.90 -0.34 - 0.11
D5S118 -~oo -4.98 - 2.20 -1.16 -0.34 -0.07
D7S513 —oo -9.04 -4.34 —2.48 -0.92 -0.28
D7S493 —OQ -4.99 -2.95 -1.98 - 0.88 -0.33
D7S516 —OO -3.20 —1.82 —1.22 -0.59 -0.24
D7S526 —oo -5.62 -2.33 -1.09 —0.14 0.16
GCK ***••00 -4.75 -2.69 —1.84 - 1.02 -0.52
EGFR -**O0 -6.96 -3.56 -2.19 -0,98 -0.41
D7S440 —oo -5.34 -3.15 -2.18 - 1.21 - 0.66
Maker order is derived from Dib et at21 *
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the location of the gene involved with the highest 
likelihood, A maximum lod score of 5.41 was found in 
the interval between D12S1339 and D12S1343 and in 
the interval between D12S1340 and D12S1672 (Fig­
ure 2). Both these regions are located between
D12S1344 and D12S1583.
The SMA in the family described by Frijns et al 
(family 2),7 closely resembles the disorder in family 1. 
Both families originated from the same geographical 
area, Therefore we analysed family 2 for linkage with 
markers derived from the interval between D12S78 and 
D12S354. In Table 3 the two-point lod scores are given. 
These lod scores exclude the interval determined in 
family 1.
individual III. 1 between the markers D12S78 and
Discussion
D12S1342. The marker D12S317 is not informative for In the present study we localised the gene responsible
this recombination. The distal border of the critical 
region is determined by a recombination between the
for congenital distal spinal muscular atrophy in family
l,5 to an interval of about 10cM in 12q23~q24,
markers D12S1583 and D12S1646. Different alleles of delimited by the markers D12S78 and D12S1646, 
the marker D12SI646 co-segregate with the disorder in However, in family 2 linkage to this interval was 
the two branches of the pedigree. Although the marker excluded.
DI2S1341 is located distal to DI2SI646 it has a high lod The disorders in family 1 and family 27 are clinically
score which is due to non-informativity of this marker very similar (Table 4). Some of the patients of family 2 
between the two branches of the pedigree (Figure 1). show a slight hyperlaxity of the upper limb joints ancl a 
Five-point linkage analysis was performed to determine mild weakness of the neck flexors. These findings are
Tabic 2 'l\vo-point lod scores between the polymorphic markers derived from chromosome 12 and the SMA in family I
family 1 e
Locua 0.00 0.01 ft 05 0.10 020 0.30 Znwx (V
D12S78 —OO 2.79 3.17 3.06 2.48 1.69 3.17 (0.05)
D12S317 1.95 1.91 1.74 1.52 1.08 0.63 1.95 (0.00)
D 1281342 4.96 4.88 4.54 4.11 3.17 2.12 4.96 (0,00)
D 12S353 1.99 1.96 1.80 1,61 1.20 0.76 1.99 (0.00)
D12S84 4.95 4.87 4.53 4.11 3.17 2.14 4.95 (0.00)
D12S1605 1.18 1.15 1.04 0.89 0.60 0.32 1.18(0.00)
D12S105 1.04 1.02 0.94 0.84 0.63 0.42 1.04 (0.00)
D12S1344 3.47 3.41 3.16 2,85 2.17 1.43 3.47 (0.00)
D12S1339 4,80 4.71 4.37 3.93 2.98 1.95 4.80 (0.00)
D12S1343 1.04 1.02 0.94 0.84 0.63 0.41 1.04 (0.00)
D12S1340 3.57 3.50 3.20 2.82 1.99 1.11 3.57 (0.00)
D12S1672 3.88 3.81 3,53 3.17 2.40 1.56 3.88 (0.00)
D12SI583 5.16 5.05 4.72 4.27 3.29 2,19 5.16 (0.00)
D12$1646 —oo 0,77 1,89 2.11 1.90 1,34 2.12 (0.11)
D12S1341 4.36 4.29 3.98 3.57 2.69 1,72 4.36 (0.00)
D12S354 -1.51 1.60 2.01 1.94 1.44 0.80 2.02 (0.06)
D12S369 —OO 0.20 1.29 1.50 1,26 0.77 1.50 (0.11)
D12S79* —OO 0.81 1.29 1.31 1.03 0.64 1.32 (0.08)
D12S366* —OO -6.45 -3.05 - 1.68 -0.51 -0.06 0.07 (0.41)
D12S349* —oo -5.71 -2.42 -1.17 - 0.22 0.06 0.08 (0.35)
D12S1639 —oo -5.81 -2.51 -1.28 -0.30 0.03 0.08 (0.37)
^Individuals III—18 and the son of 111-20 are not involved in the analysis.
Marker order, given from centromere to telomere, is derived from Kucherlapati et al2$ and Dib et al21
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Figure 2 Five-point linkage analysis combined with the sliding window technique resulting in a maximum lod score o f 5.41 in the 
interval between D12S1339 and D12S1343 and in the interval between D12S1340 and D12S1672. The markers located between 
D12S1344 and D12S1583 represented by the lines are, from left the right, D12S1339, D12S1343, D12S1340 and D12S1672.
not present in the patients of family 1. McKusick 
presents both disorders under the same MIM number
Table 3 Two-point lod scores between the polymorphic 
markers derived from chromosome 12q23-q24 and the 
disorder in family 2
family 2
Locus 0.00 0.01 0.05 0.10 0.20 0.30
D12S78 «■h Q Q -2.80 -1.44 -0.89 -0.39 -0.15
D12S317 — O O -3.91 - 1.88 - 1.08 -0.38 -0.08
D12S84 ....... o o 0.02 0.02 0.02 0.02 0.01
D12S1344 — o o - 1.11 -0.44 -0.19 0.01 0.07
D12S1339 -3.91 - 1.88 -1.08 -0.38 -0.08
D12S1583 — o o -3.91 - 1.88 -1.08 -0.38 -0.08
D12S1646 *••*» 0 0 -2.71 -1,36 -0.82 -0.34 -0.13
D12S354 — o o -4.21 -2.16 -1.33 -0.58 -0.23
Maker order, given from centromere to telomere, is derived 
from Kucherlapati et a I25 and Dib et al21.
(MIM 600175). Our results indicate genetic heteroge­
neity for this type of SMA.
Interestingly, the locus for the type of spinal muscular 
atrophy in family I has overlap with the locus for 
SPSMA,14 which has been mapped to the 19cM 
interval between D12S338 and D12S366 (Figure 3). 
However, clinically the two disorders are different 
(Table 4). At birth, the most remarkable feature of this 
autosomal dominant form of SPSMA is stridurous 
breathing due to laryngeal palsy. Lower limb weakness 
and contractures appear in the first or second decade 
only, indicating a progressive course of the disease. In 
contrast, the SMA in family 1 presents with con­
tractures at birth, is limited to the lower extremities and 
is not progressive. Therefore, allelism of both disorders 
does not seem very likely. If they are allelic, the critical 
region for the gene involved is determined by the 
markers D12S338 and D12S1646. The locus for distal
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Table 4 Clinical; comparison of scapulo peroneal spinal muscular atrophy (SPSMA)6 and the disorders described by Fleury and 
Hagermuv' and Frijns et a I7
SPSMA Family 1 by Fleury and Hage man Family 2 by Frijns et al
mode of inheritance 
age of onset 
signs at birth
involvement
progression
deep tendon reflexes 
sensory
motor
I  »
autosomal dominant 
birth
stridurous respiration, congenital 
absence of muscle groups, legs not 
heavily involved
larynx, neck, scapular musculature 
and lower extremities
(mainly in distal parts of
extremities)
absent
absence of vibration sense at
256 Hz
progression to atrophied and 
paretic lower limb muscles
anticipation +
autosomal dominant 
birth
weakness and congenital 
contractures in lower limbs
lower extremities and truncal 
muscles
dominant
birth
weakness and congenital 
contractures in lower limbs
lower extremities and paraspinal 
muscles, in some: masseteric, 
neck, shoulder girdle and upper 
limb musculature
reduced to absent 
intact
reduced to absent 
intact
paretic proximal lower limbs and paresis of lower limbs and 
pelvic girdle, paralytic distal lower and lumbar paraspinal muscles 
limbs
12cen
9.5
11 .0
1.3
12.4
D12S78 
D12S338
SCA2
D12S1646 SPSMA
congenital 
distal SMA
D12S366 
D12S86
D12S340
distal HMNII
hereditary motor neuropathy type II (distal HMNI1)22 
is located distal to the locus for the present SMA and is 
excluded by the markers D12S366, D12S349 and 
D12S1639 (Table 2). The locus for autosomal dominant 
scapuloperoneal muscular dystrophy is located prox­
imal to the locus for the present SMA.23
There are no very obvious candidate genes known in 
the critical region of the present disorder. However, a 
number of genes localised in or around the interval or 
mapped with overlap to the critical region, can be 
regarded as candidates. These are, among others: 
protein phosphatase 1 catalytic gamma isoform 
(PPP1CC); protein tyrosine phosphatase non-receptor 
type 11 (PTPN11); nuclear transcription factor Y  
B-subunit (NFYB); the gene for spinocerebellar ataxia 
(SCA2) and mitogen activating protein kinase activated 
protein kinase 2 (MPAKAP kinase2) 24'2f' OMIM. The 
nitric oxide synthase 1 (NOS1) gene, discussed as a 
candidate for SPSMA,14 is located outside the critical 
region of the present SMA.
12qter
Figure 3 Genetic map o f chromosome L2q23-q24 with the 
location o f three hereditary motor neuron diseases marked by 
bars. Distances are given in cM based on sex average 
recombination fractions. SCA2, spinocerebeller ataxia type 2.
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